Stay updated on Zolbetuximab Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.

Latest updates to the Zolbetuximab Combo in Gastric Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe webpage has been updated to include new details about the clinical study of Zolbetuximab (IMAB362) plus mFOLFOX6, including the study's purpose, treatment protocols, and follow-up procedures. Additionally, the results reporting dates have been clarified.SummaryDifference46%
- Check36 days agoChange DetectedThe website has updated to revision v2.14.2, noting that some NLM-NCBI services are experiencing heavy traffic, which may impact performance and availability.SummaryDifference0.6%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.14.1, replacing the previous version v2.14.0 which was first posted on September 13, 2023.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.1%
- Check86 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check93 days agoChange DetectedThe website has been updated from version 2.13.0 to 2.13.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Zolbetuximab Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zolbetuximab Combo in Gastric Cancer Clinical Trial page.